From Surf Wiki (app.surf) — the open knowledge base
HLA-DR2
Antigen serotype
Antigen serotype
HLA-DR2 (DR2) of the HLA-DR serotype system, is a broad antigen serotype that is now preferentially covered by HLA-DR15 and HLA-DR16 serotype group. This serotype primarily recognizes gene products of the HLA-DRB115 and HLA-DRB116 allele groups.
Serology
Disease associations
DR2 serotypes are associated with Goodpasture syndrome, systemic lupus erythematosus, multiple sclerosis, narcolepsy, tuberculoid leprosy (multi-drug-resistant tuberculosis or leprosy), ulcerative colitis (Japanese), primary biliary cirrhosis and autoimmune hepatitis. DR2 is also found in all patients that test positive for anti-Asn-RNA-synthetase and chronic interstitial lung disease.
Genetic linkage
DR2 is linked to the HLA-DR51.
References
References
- [http://www.ebi.ac.uk/imgt/hla/allele.html derived from IMGT/HLA]
- (1981). "HLA family studies and multiple sclerosis: A common gene, dominantly expressed.". Hum Immunol.
- (1980). "HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker.". J Infect Dis.
- (2007). "Immunogenetics of mycobacterial infections in the North Indian population". Tissue Antigens.
- (1982). "Association of the human lymphocyte-DR2 antigen with Japanese ulcerative colitis.". Gastroenterology.
- (1983). "HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis.". Digestion.
- (2007). "Clinical and immunogenetic features of patients with autoantibodies to asparaginyl-transfer RNA synthetase". Arthritis Rheum..
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about HLA-DR2 — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report